A must-attend meeting
This is Asia’s first event dedicated to addressing the challenges faced by pharma professionals responsible for strategic sourcing, procurement and outsourcing. A must attend meeting for pharma executives in the business of or considering sourcing from Asia and outsourcing to Asia.
It is estimated that China could be the world’s 2nd or 3rd largest pharmaceutical market by 2020 – Does your sourcing strategy give you a piece of the lucrative ‘China-pie’?
Pharma sourcing, procurement and outsourcing issues from end-to-end
Whether it is in discovery through research & development to manufacturing and supply, your priority is in managing costs and promoting growth through strategic sourcing. This is your unique opportunity to gather insights from your peers while discussing strategies for innovative partnerships.
The region’s first to market event focusing on the strategic needs of procurement and sourcing professionals specific to the pharma industry
The ONLY event of its kind in Asia to focus on the entire value-chain – end-to-end from discovery to patient – how to optimize your sourcing function to manage costs and create value across the organization
Practical industry advice and strategic discussion on how companies can enhance the sourcing function to create value and drive down costs
Your chance to meet leading suppliers across the region and engage in meaningful discussion about collaborative partnerships and innovative ventures to make your activities more cost effective
Discuss novel strategies to develop effective partnership models moving from price-based to a total value relationship
Director, Global Procurement Asia Pacific
|Dr. Dittmar K. Nerger
Head of Strategic Sourcing and Compliance Healthcare
Bayer Healthcare Ltd., China
|Dachen Cheng Ph.D
China Sourcing Team Leader
Pharmaceutical Development, R&D Supply Chain, AstraZeneca, China
|Stephen Scypinski Ph.D.
Analytical & Bioanalytical Development, Bristol-Myers Squibb Company, USA
Head of Procurement, Alcon (China)
a Novartis company, China